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Introduction:  
Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among all cancers due to late-
stage diagnosis, limited detection and treatment methods. MiRNAs are post-transcriptional regulators, 
recently reported to have numerous functions, including  modulation of cellular differentiation, 
proliferation, and apoptosis, Several tumor suppressors, such as PTEN, TPM1, and PDCD4 were 
identified as miR-21 targets. MiR-21 is stable in both tissues and plasma, disease-specific  and 
therefore it appears to be a promising biomarker for benign and malignant diseases of pancreas. 
Current evidence suggests that  miR-21 overexpression is associated with shorter overall survival, 
higher rate of liver and regional lymph nodes metastases.  
Aim of study:  
The purpose of the study is to review the current literature on the evaluation of miR-21 as a prognostic 
biomarker in PDAC, as well as influence of miR-21 on pancreatic cancer cells. 
Materials and Methods:  
Review of English language articles from PubMed addressing the link between miR-21 and PDAC.  
Results:  
In the analysed articles, increased miR-21 is associated with significant decrease of overall and 
progression-free survival in patients with PDAC.  In addition miR-21 upregulation is linked with poor 
tumor differentiation and lymph nodes metastasis regardless of sample source, either tissue or 
circulation samples. The miR-21 has been found to be elevated very early in pancreatic neoplasia. 
Interestingly, inhibition of miR-21 decreased chemoresistance for gemcitabine of pancreatic cancer 
cells. 
Conclusion:  
According to the latest literature, miR-21 contributed to proliferation, invasion, and chemoresistance of 
pancreatic cancer cells. In conclusion, miR-21 may serve as a useful prognostic biomarker and 
potential target for pancreatic cancer therapy.  
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